INSR, insulin receptor, 3643

N. diseases: 452; N. variants: 109
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.700 AlteredExpression disease BEFREE This suggests that treatment of adiponectin effectively improves testicular functions by increasing expression of insulin receptor-mediated increased transport of energy substrate (glucose and lactate) and a marked reduction in oxidative stress are the possible mechanism by which adiponectin effectively improves testicular function in T2D mice. 31676315 2020
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.600 Biomarker disease BEFREE Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease. 31823898 2020
CUI: C0011882
Disease: Diabetic Neuropathies
Diabetic Neuropathies
0.520 Biomarker group BEFREE Here, we created an insulin resistant SC by deleting both insulin receptor (INSR) and insulin-like growth factor receptor 1 (IGF1R), to determine the role of this signaling pathway in development and response to injury in order to understand SC defects in DN. 31758725 2020
CUI: C0020459
Disease: Hyperinsulinism
Hyperinsulinism
0.500 GeneticVariation disease BEFREE The increased insulin sensitivity responsiveness in Grb10-silenced myotubes was associated with higher abundance of the insulin receptor. 31794259 2020
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.400 Biomarker phenotype BEFREE Congenital beta cell-specific IR knockout (βIRKO) mouse studies have demonstrated the development of age-dependent glucose intolerance. 31541682 2020
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.300 AlteredExpression phenotype BEFREE Insulin restores these alterations in GDM via activation of insulin receptor A (IR-A) form in the macrovascular but IR-A and IR-B forms in the microcirculation of the human placenta. 30660686 2020
CUI: C0032460
Disease: Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
0.200 GeneticVariation disease BEFREE The association of INSR (INSulin Receptor gene) variants (rs2059807 and rs1799817) with PCOS was established through genome-wide association studies, yet requires validation for the Indian population. 31837364 2020
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.180 Biomarker disease BEFREE Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer's disease. 31823898 2020
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 GeneticVariation disease BEFREE Although these findings need validation, rotating night shift might increase colorectal cancer risk in women with abnormal insulin receptor pathways. 31666286 2020
Malignant neoplasm of colon and/or rectum
0.070 GeneticVariation disease BEFREE Although these findings need validation, rotating night shift might increase colorectal cancer risk in women with abnormal insulin receptor pathways. 31666286 2020
CUI: C0948379
Disease: Impaired insulin secretion
Impaired insulin secretion
0.030 Biomarker disease BEFREE Postnatal knockout of beta cell insulin receptor impaired insulin secretion in male mice exposed to high-fat diet stress. 31541682 2020
CUI: C0342257
Disease: Complications of Diabetes Mellitus
Complications of Diabetes Mellitus
0.010 GeneticVariation group BEFREE Patients with mutations of the insulin receptor gene (INSR) have extreme insulin resistance and are at risk for early morbidity and mortality from diabetes complications. 31588494 2020
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Correction to: Functional Polymorphism Located in the microRNA Binding Site of the Insulin Receptor (INSR) Gene Confers Risk for Type 2 Diabetes Mellitus in the Bangladeshi Population. 30062661 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE Disruption of INSR-coupled activities has been identified in a wide range of insulin resistance-related diseases such as T2DM. 31658625 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 AlteredExpression disease BEFREE PBMCs incubated for 1 hour with plasma from T2DM and pre-T2DM participants had significantly lower levels of insulin receptor density compared to those incubated with plasma from control participants (<i>p</i> < 0.001). 30964398 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Our study showed that the miRNA binding site polymorphism rs1366600 located at the 3'-UTR region of the INSR gene is associated with increased risk of T2DM in Bangladeshi individuals. 29971619 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 AlteredExpression disease BEFREE In this review, we discuss the role of insulin and the INSR in the development and endocrine activity of adipose tissue and the pharmacological implications for the management of obesity and type 2 diabetes. 30754657 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 AlteredExpression disease BEFREE The results described here support restoration of IR expression as a safe and effective T2DM therapeutic with a long-lasting profile. 31391336 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 AlteredExpression disease BEFREE Beyond these physiological roles of insulin, a shared feature between the periphery and CNS is that decreases in insulin receptor activity and signaling (i.e. insulin resistance) contributes to the pathological consequences of type 2 diabetes (T2DM) and obesity. 31028829 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE Abbreviations: AC: adenylyl cyclase; AMPK: AMP-activated protein kinase; βAR: β-adrenergic receptor; CA: catecholamine; cAMP: cyclic adenosine monophosphate; cGMP: cyclic guanosine monophosphate; DPP-4: dipeptidyl peptidase-4; ERK: extracellular signal-regulated kinase; GC: guanylyl cyclase; GH: growth hormone; GLP-1: glucagon-like peptide-1; GLUT: glucose transporter; HSL: hormone-sensitive lipase; IR: insulin receptor; IRS: insulin receptor substrate; MAPK: mitogen-activated protein kinase; MEK: MAPK/ERK kinase; MG: maltase-glucoamylase; NP: natriuretic peptide; NPR: natriuretic peptide receptor; mTORC2: mechanistic target of rapamycin complex-2; PC: proanthocyanidin; PI3K: phosphoinositide 3-kinase; PKA: cAMP-dependent protein kinase; PKB (AKT): protein kinase B; PKG: cGMP-dependent protein kinase; PPARγ: peroxisome proliferator-activated receptor-γ; SGLT1: sodium-dependent glucose transporter 1; SI: sucrase-isomaltase; T2DM: type 2 diabetes mellitus; TNFα: tumor necrosis factor-α. 30773997 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE The pathophysiology of type 2 diabetes mellitus (T2D) is characterized by reduced or absent insulin receptor (INSR) responsiveness to its ligand, elevated hepatic glucose output and impaired glucose uptake in peripheral tissues, particularly skeletal muscle. 31378829 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE Mitsugumin 53 (MG53 or TRIM72), a striated muscle-specific E3 ligase, promotes ubiquitin-dependent degradation of the insulin receptor and insulin receptor substrate-1 and subsequently induces insulin resistance, resulting in metabolic syndrome and type 2 diabetes mellitus (T2DM). 30586741 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE The Protein Tyrosine Phosphatase (PTP1b) is the main enzyme involved in insulin receptor desensitization and has become a drug target for the treatment of Diabetes type II. 30714526 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE Mulberry leaf active components alleviate type 2 diabetes and its liver and kidney injury in db/db mice through insulin receptor and TGF-β/Smads signaling pathway. 30780108 2019
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.600 AlteredExpression disease BEFREE Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease. 30635783 2019